• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同步(AC)n微卫星多态性分析和单链构象多态性筛查是检测显性遗传性球形红细胞增多症中锚蛋白-1突变的有效策略。

Simultaneous (AC)n microsatellite polymorphism analysis and single-stranded conformation polymorphism screening is an efficient strategy for detecting ankyrin-1 mutations in dominant hereditary spherocytosis.

作者信息

Ozcan Refik, Jarolim Petr, Lux Samuel E, Ungewickell Ernst, Eber Stefan W

机构信息

Universitäts-Kinderklinik, Goettingen, Germany.

出版信息

Br J Haematol. 2003 Aug;122(4):669-77. doi: 10.1046/j.1365-2141.2003.04479.x.

DOI:10.1046/j.1365-2141.2003.04479.x
PMID:12899723
Abstract

Nonsense/stop mutations in the ankyrin-1 gene (ANK1) are a major cause of dominant HS (dHS) (frequency of 23% in German dHS patients). To date, no common mutation has been found and therefore a simple mutation screening is not feasible. The reduced expression of one cDNA allele in the (AC)n microsatellite polymorphism of the ankyrin-1 gene, as seen in about 20% of Czech patients with dHS, may identify candidates with a possible frameshift/nonsense mutation. In order to verify the efficiency of this screening we screened the ankyrin-1 gene of 22 Czech dHS patients for both the reduced cDNA allele expression in the frequent (AC)n and the common exonic 26/39 polymorphisms, as well as for polymerase chain reaction (PCR) single-stranded conformation polymorphisms in any one of the 42 exons of ANK1. Anomalous PCR products were sequenced. We found seven new ANK1 frameshift/nonsense mutations in nine patients with, but in none of six patients without, a reduced cDNA allele expression (efficiency of 78%). We conclude that screening of dHS patients for such a reduced allele expression in common ANK1 polymorphisms is an efficient procedure for the identification of candidates for frameshift/nonsense mutations in the ankyrin-1 gene.

摘要

锚蛋白-1基因(ANK1)中的无义/终止突变是显性遗传性球形红细胞增多症(dHS)的主要病因(在德国dHS患者中的发生率为23%)。迄今为止,尚未发现常见突变,因此简单的突变筛查不可行。在约20%的捷克dHS患者中观察到,锚蛋白-1基因(AC)n微卫星多态性中一个cDNA等位基因的表达降低,这可能识别出存在可能的移码/无义突变的候选者。为了验证这种筛查的效率,我们对22例捷克dHS患者的锚蛋白-1基因进行了筛查,检测常见(AC)n中cDNA等位基因表达降低情况、常见的外显子26/39多态性,以及ANK1的42个外显子中任何一个的聚合酶链反应(PCR)单链构象多态性。对异常PCR产物进行测序。我们在9例cDNA等位基因表达降低的患者中发现了7个新的ANK1移码/无义突变,但在6例cDNA等位基因表达未降低的患者中均未发现(效率为78%)。我们得出结论,对dHS患者进行常见ANK1多态性中这种等位基因表达降低情况的筛查,是识别锚蛋白-1基因移码/无义突变候选者的有效方法。

相似文献

1
Simultaneous (AC)n microsatellite polymorphism analysis and single-stranded conformation polymorphism screening is an efficient strategy for detecting ankyrin-1 mutations in dominant hereditary spherocytosis.同步(AC)n微卫星多态性分析和单链构象多态性筛查是检测显性遗传性球形红细胞增多症中锚蛋白-1突变的有效策略。
Br J Haematol. 2003 Aug;122(4):669-77. doi: 10.1046/j.1365-2141.2003.04479.x.
2
High frequency of de novo mutations in ankyrin gene (ANK1) in children with hereditary spherocytosis.遗传性球形红细胞增多症患儿锚蛋白基因(ANK1)的新发突变频率较高。
J Pediatr. 1998 Jan;132(1):117-20. doi: 10.1016/s0022-3476(98)70495-0.
3
A recurrent frameshift mutation of the ankyrin gene associated with severe hereditary spherocytosis.
Br J Haematol. 2000 Dec;111(4):1190-3. doi: 10.1046/j.1365-2141.2000.02441.x.
4
Comparison of the ankyrin (AC)n microsatellites in genomic DNA and mRNA reveals absence of one ankyrin mRNA allele in 20% of patients with hereditary spherocytosis.基因组DNA和信使核糖核酸中锚蛋白(AC)n微卫星的比较显示,20%的遗传性球形红细胞增多症患者的一个锚蛋白信使核糖核酸等位基因缺失。
Blood. 1995 Jun 1;85(11):3278-82.
5
Ankyrin Napoli: a de novo deletional frameshift mutation in exon 16 of ankyrin gene (ANK1) associated with spherocytosis.锚蛋白那不勒斯:一种与球形红细胞增多症相关的锚蛋白基因(ANK1)第16外显子的新发缺失移码突变。
Br J Haematol. 1996 Jun;93(4):828-34. doi: 10.1046/j.1365-2141.1996.d01-1746.x.
6
Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency.遗传性球形红细胞增多症伴带3缺乏症中13种新型带3基因缺陷的特征分析。
Blood. 1996 Dec 1;88(11):4366-74.
7
(AC)n microsatellite polymorphism and 14-nucleotide deletion in exon 42 ankyrin-1 gene in several families with hereditary spherocytosis in a population of South-Western Poland.波兰西南部人群中几个遗传性球形红细胞增多症家族的(AC)n微卫星多态性及锚蛋白-1基因第42外显子的14核苷酸缺失
Ann Hematol. 2006 May;85(5):337-9. doi: 10.1007/s00277-006-0083-7. Epub 2006 Mar 4.
8
Ankyrin gene mutations in japanese patients with hereditary spherocytosis.日本遗传性球形红细胞增多症患者的锚蛋白基因突变
Int J Hematol. 2001 Jan;73(1):54-63. doi: 10.1007/BF02981903.
9
Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis.锚蛋白-1突变是显性和隐性遗传性球形红细胞增多症的主要病因。
Nat Genet. 1996 Jun;13(2):214-8. doi: 10.1038/ng0696-214.
10
A tetranucleotide deletion in the ANK1 gene causes hereditary spherocytosis; a case of misdiagnosis.ANK1 基因中的四核苷酸缺失导致遗传性球形红细胞增多症;一例误诊。
Gene. 2020 Feb 5;726:144226. doi: 10.1016/j.gene.2019.144226. Epub 2019 Oct 26.

引用本文的文献

1
Clinical and genetic diagnosis for 26 paitents with hereditary spherocytosis.遗传性球形红细胞增多症 26 例的临床与基因诊断。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Apr 28;48(4):565-574. doi: 10.11817/j.issn.1672-7347.2023.220390.
2
[The characteristic of hereditary spherocytosis related gene mutation in 37 Chinese hereditary spherocytisis patients].[37例中国遗传性球形红细胞增多症患者遗传性球形红细胞增多症相关基因突变特征]
Zhonghua Xue Ye Xue Za Zhi. 2018 Nov 14;39(11):898-903. doi: 10.3760/cma.j.issn.0253-2727.2018.11.005.
3
α-thalassaemia combined with hereditary spherocytosis in the same patient.
同一患者中α地中海贫血合并遗传性球形红细胞增多症。
Exp Ther Med. 2018 Feb;15(2):1298-1303. doi: 10.3892/etm.2017.5579. Epub 2017 Nov 28.
4
A novel ENU-generated truncation mutation lacking the spectrin-binding and C-terminal regulatory domains of Ank1 models severe hemolytic hereditary spherocytosis.一种新型ENU 诱导的截断突变,缺乏 Ank1 的 spectrin 结合和 C 末端调节结构域,可模拟严重遗传性球形红细胞增多症。
Exp Hematol. 2011 Mar;39(3):305-20, 320.e1-2. doi: 10.1016/j.exphem.2010.12.009. Epub 2010 Dec 28.
5
Ankyrin-linked hereditary spherocytosis in an African-American kindred.一名非裔美国家族中的锚蛋白相关遗传性球形红细胞增多症。
Am J Hematol. 2008 Oct;83(10):789-94. doi: 10.1002/ajh.21254.